Prospective Cohort With Hemopathy in Languedoc-Roussillon (HemoDiag)

University Hospital Center (CHU)

Status: Enrolling

Conditions: Hematologic Malignancy

Treatments: Biological: hematologic malignancy

Study type: Observational

Funder types: Other

Identifiers

NCT02134574

9011

Details and patient eligibility

About

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

Full description

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy in LR.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18
• Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent
• Having signed an informed consent
• Affiliated with a social security scheme

Exclusion criteria

• Minor or major protected
• Patients who have received treatment for hematological pathology

Trial design

500 participants in 1 patient group

hematologic malignancy

Description:

hematologic malignancy with a sampling of blood

Treatment:

Biological: hematologic malignancy